Glimpse at the complexity of drug prices
I feel that there is considerable confusion about drug prices amongst industry outsiders. Until I started looking into the topic, I had no idea how complex it was.
I feel that there is considerable confusion about drug prices amongst industry outsiders. Until I started looking into the topic, I had no idea how complex it was.
In 2019, I graduated with Distinction from the roller-coaster that was my one-year full-time MSc in Finance and Investment Management at the University of Aberdeen, Scotland.
Considering the importance of antibiotics for our healthcare, the issue of a dwindling development pipeline must be addressed. This article outlines various economic suggestions.
Scientists in academic or other institutions use the unique insights patients provide to inform their research. Pharmaceutical companies oftentimes look for customer input primarily in late development stages. So far however, their main focus has been on […]
This is a comment on the following publication: Erik Malmqvist (2019) “Paid to Endure”: Paid Research Participation, Passivity, and the Goods of Work, The American Journal of Bioethics, 19:9, 11-20, DOI:10.1080/15265161.2019.1630498
It may be hard to believe but a pharmacy talk can actually be entertaining. Prof Derek Stewart made sure of that whilst conveying some important key insights of his group’s research.